Aseptic Sampling Market Research Report Information By Type (Manual Aseptic Sampling, Automated Aseptic Sampling), Technique (Off-Line Sampling Technique, Other Technique), Application (Upstream Process, Other Process), End-user- Forecast Till 2032

Aseptic Sampling Market Overview 

The aseptic sampling market size is expected to reach USD 0.8 billion by 2032 at 11% CAGR during the forecast period 2023-2032. The market is expected to develop due to rising demand for biopharmaceuticals and rising usage of single-use aseptic sampling systems, which offer benefits such as enhancing process efficiency and lowering the risk of product contamination. To avoid contamination during the sample collecting process, an aseptic sample is obtained in sterile circumstances. Furthermore, aseptic sampling market expansion is projected to be aided by the presence of strong government laws ensuring drug safety. The aseptic sampling market is expected to be dominated by Europe. Increased R&D efforts and the rising biopharmaceutical sector are driving market expansion in this area. Furthermore, governments in several European countries are assisting pharmaceutical companies in the development of new biopharmaceutical products. This element is predicted to contribute to market expansion. Because of strict government restrictions on pharmaceutical product safety and quality, as well as the presence of a well-established healthcare system, the Americas are likely to be the second-largest market for aseptic sampling. Furthermore, rising government spending in the healthcare sector is expected to help market expansion in this region.

Key players

Some of the key players in the aseptic sampling market are Merck KGaA, Sartorius Stedim Biotech, Thermo Fisher Scientific, Danaher Corporation, Saint Gobain, GEA Group, Qualitru Sampling Systems, Keofitt, Gemü Group, W. L. Gore & Associates, Flownamics Analytical Instruments, Lonza Group, Trace Analytics, and Bürkle GmbH.

Segmentation

The aseptic sampling market has been segmented into type, technique, application, and end-user.

The market on the basis of type has been segmented into manual aseptic sampling and automated aseptic sampling. The manual aseptic sampling segment, by product, has been further segmented into bags, syringes, accessories, and bottles. The manual aseptic sampling segment, by type, has been segmented into traditional and single-use.

The market, by technique, has been segmented into off-line sampling technique, on-line sampling, and at-line sampling.

The market, by application, has been segmented into upstream process and downstream process.

On the basis of end-user, the aseptic sampling market has been segmented into pharmaceutical and biotechnology companies, research and development institutes, and contract research and manufacturing organizations.

On a regional basis, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The aseptic sampling market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European aseptic sampling market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The aseptic sampling market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The aseptic sampling market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Global Aseptic Sampling Market Share (%), by Region, 2017

Source: Food and Drug Administration (FDA), Office for National Statistics, Centers for Disease Control and Prevention (CDC)

Geographically, Europe is anticipated to dominate the aseptic sampling market. The market growth in this region is attributed to increasing R&D activities and the growing biopharmaceutical sector.

Moreover, governments in several European countries are supporting pharmaceutical companies to launch new biopharmaceutical products. This factor is expected to contribute to the growth of the market. According to the Office for National Statistics, the gross domestic expenditure on Research and Development (R&D) was EUR 33.1 billion (USD 35.2 billion) in 2016.

The Americas is expected to be the second largest market in aseptic sampling owing to the stringent government regulations on safety and quality of pharmaceutical products and the presence of a well-established healthcare system. Additionally, increasing government expenditure for the healthcare sector is anticipated to contribute to the market growth in this region. According to the Centers for Disease Control and Prevention, the total national health expenditure was USD 3.2 trillion in 2015.

Asia-Pacific is anticipated to be the fastest growing market owing to the growing developments in healthcare infrastructure, increasing number of regional expansions by multinational biopharmaceutical companies, and increasing government expenditure for the healthcare sector.

The Middle East and Africa is anticipated to account for the lowest market share in the aseptic sampling market due to low development, lack of technical knowledge, and poor medical facilities in developing economies in this region.

Aseptic Sampling Market, by Type

• Manual Aseptic Sampling

Aseptic Sampling Market, by Product

• Bags


• Syringes


• Bottles


• Accessories

   Aseptic Sampling Market, by Type

• Traditional


• Single-Use

• Automated Aseptic Sampling Equipment

Aseptic Sampling Market, by Technique

• Off-Line Sampling Technique


• On-Line Sampling Technique


• At-Line Sampling Technique

Aseptic Sampling Market, by Application

• Upstream Process


• Downstream Process

Aseptic Sampling Market, by End-User

• Pharmaceutical and Biotechnology Companies


• Research and Development Institutes


• Contract Research and Manufacturing Organizations

Aseptic Sampling Market, by Region

Americas

• North America


• US


• Canada


• South America

Europe

• Western Europe


• Germany


• France


• Italy


• Spain


• UK


• Rest of Western Europe


• Eastern Europe

Asia-Pacific

• Japan


• China


• India


• Australia


• South Korea


• Rest of Asia-Pacific

Middle East & Africa

• Middle East


• Africa

Recent Development

Merck revealed its ambitions to build a new biotech development site in Switzerland in 2020. The facility will focus on biotech drug development and clinical trial manufacturing. For this goal, the corporation will invest USD 282.5 million. Thermo Fisher Scientific announced a USD 475 million investment in new capabilities and capacities in 2020 to meet the growing need for biologics, cell and gene treatments, and pharma products. This investment, combined with those made in 2019, brings the overall investment in the company's pharma services sector to around USD 800 million over two years. Pall Corporation (US) and University College London (UCL) inked a collaboration agreement in 2018. (UK). The goal of this collaboration was to create the UCL-Pall Biotech Centre of Excellence (CoE).

Intended Audience

• Biopharmaceutical manufacturers


• Pharmaceutical manufacturers


• Contract Research Organizations (CROs)


• Contract Manufacturing Organizations (CMOs)

Report Scope:

Report Attribute/Metric	Details
Market Size	2030: 0.8 billion
CAGR	11%
Base Year	2021
Forecast Period	2023-2032
Historical Data	2020
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Type, Technique, Application, and End-user
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Merck KGaA, Sartorius Stedim Biotech, Thermo Fisher Scientific, Danaher Corporation, Saint Gobain, GEA Group, Qualitru Sampling Systems, Keofitt, Gemü Group, W. L. Gore & Associates, Flownamics Analytical Instruments, Lonza Group, Trace Analytics, and Bürkle GmbH.
Key Market Opportunities	·  Improving process efficiency ·  Reducing the risk of product contamination ·  Presence of stringent government regulations for ensuring drug safety
Key Market Drivers	·  Growing demand for biopharmaceuticals ·  Increasing adoption of single-use aseptic sampling systems

Frequently Asked Questions (FAQ) :